Hemolytic anemia during 24 weeks of ribavirin and interferon-α2b combination therapy does not influence the cardiac function of patients with viral hepatitis C

被引：0
|
作者：
Sato, S [1 ]
Furuta, K
Miyake, T
Mishiro, T
Kohge, N
Akagi, S
Uchida, Y
Rumi, MAK
Ishihara, S
Adachi, K
Kinoshita, Y
机构：
[1] Shimane Univ, Sch Med, Dept Gastroenterol & Hepatol, Matsue, Shimane, Japan
[2] Shimane Univ Hosp, Div Gastrointestinal Endoscopy, Matsue, Shimane, Japan
来源：
JOURNAL OF CLINICAL GASTROENTEROLOGY | 2006年 / 40卷 / 01期
关键词：
D O I：
10.1097/01.mcg.0000190781.96021.20
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：88 / 89
页数：2
相关论文
共 50 条
  • [1] Effect of combination therapy with ribavirin and high-dose interferon-α2b for 24 weeks in chronic hepatitis C
    Abe, S
    Narita, R
    Oto, T
    Tabaru, A
    Otsuki, M
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (01) : 308 - 312
  • [2] Combination Therapy with Interferon-α2b, Ribavirin, and Amantadine in Chronic Hepatitis C Nonresponders to Interferon and Ribavirin
    Paul J. Thuluvath
    Hemant Pande
    Joyce Maygers
    Digestive Diseases and Sciences, 2003, 48 : 594 - 597
  • [3] Combination therapy with interferon-α2b, ribavirin, and amantadine in chronic hepatitis C nonresponders to interferon and ribavirin
    Thuluvath, PJ
    Pande, H
    Maygers, J
    DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (03) : 594 - 597
  • [4] Interferon alfa 2b and ribavirin combination therapy for patients with chronic viral hepatitis C failing interferon therapy
    Galica, M
    Alhajjar, B
    Salen, G
    Dyrszka, H
    Sanghavi, B
    Eskreis, D
    HEPATOLOGY, 1998, 28 (04) : 709A - 709A
  • [5] Interferon-β induction/interferon-α2b plus ribavirin therapy in patients with chronic hepatitis C
    Kim, KI
    Sasase, N
    Taniguchi, M
    Mita, K
    Kinoshita, K
    Togitani, T
    Shikata, M
    Kimura, N
    Izawa, S
    Ohtani, A
    Nakao, K
    Muramoto, Y
    Kim, SR
    Nabeshima, S
    Ishii, F
    Tanaka, K
    Hayashi, Y
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH, 2005, 25 (02) : 71 - 76
  • [6] Interferon alfa 2B and ribavirin combination therapy for patients with chronic viral hepatitis C failing interferon monotherapy.
    Hajjar, B
    Galica, M
    Weisz, K
    Salen, G
    Dieterich, DT
    HEPATOLOGY, 1999, 30 (04) : 624A - 624A
  • [7] Hepatitis C viral kinetics during PEG Interferon α-2b and ribavirin therapy in naive chronic hepatitis C patients
    Boland, G.
    van Soest, H.
    de Vries, R. A.
    van Ooteghem, N. A. M.
    van Hoek, B.
    Drenth, J. P. H.
    de Knegt, R. J.
    Lieverse, R. J.
    Houben, P.
    Veer, A. van der Sluys
    Siersema, P. D.
    van Loon, A. M.
    van Erpecum, K. J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (03) : A64 - A64
  • [8] Hepatitis C virus genotype 4 and response to combination therapy with interferon-α2b plus ribavirin
    Bruno, S
    Crosignani, A
    Pinzello, GB
    ANNALS OF INTERNAL MEDICINE, 2000, 133 (11) : 922 - 923
  • [9] Efficacy and safety of combination therapy with interferon-α2b and ribavirin for chronic hepatitis C in HIV-infected patients
    Landau, A
    Batisse, D
    Van Huyen, JPD
    Piketty, C
    Bloch, F
    Pialoux, G
    Belec, L
    Petite, JP
    Weiss, L
    Kazatchkine, M
    AIDS, 2000, 14 (07) : 839 - 844
  • [10] Chronic hepatitis C in HIV-coinfected patients:: Feasibility and efficacy of interferon-α2b and ribavirin combination therapy
    Nasti, G
    di Gennaro, G
    Rizzardini, G
    Cadorin, L
    Tirelli, U
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 (03) : 299 - 300
12345